The Kable

The Kable

Friday Kable

💉 New net-zero standards outlined; An AI tool for eye diseases; AstraZeneca’s cancer platform for Africa

#214 | China eases Covid rules while maintaining Zero Covid

Vinod's avatar
Vinod
Nov 11, 2022
∙ Paid

Hello, and welcome back to The Kable for the last time in what has been a fairly hectic week, not just because of COP27.

If at first, you don't succeed, try again. And again. Till you finally get a nod for your Covid vaccine, like Sanofi and GSK have done with the EU approving their next-gen vaccine as a booster.

Another Covid vaccine player, AstraZeneca,

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 The Kable · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture